RnRMarketResearch adds ‘Hyperuricemia Pipeline Review, H1 2015’ to its store. This report provides comprehensive information on the therapeutic development for Hyperuricemia, complete with comparative analysis at various stages.

1. Browse more reports on Therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .
Hyperuricemia Pipeline Review and Drug Analysis 2015
By
RnRMarketResearch
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Publisher Name : Global Markets Direct
Date: 29-Apr-2015
No. of pages: 63
Single User License: US $2000

2. Global Markets Direct’s, ‘Hyperuricemia Pipeline Review, H1 2015′,
provides an overview of the Hyperuricemia’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic
development for Hyperuricemia, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. It also reviews key
players involved in the therapeutic development for Hyperuricemia and
special features on late-stage and discontinued projects.
Hyperuricemia Pipeline Review and Drug
Analysis 2015
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441

3. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Hyperuricemia Pipeline Review and Drug
Analysis 2015
Global Markets Direct’s report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications. The
report enhances decision making capabilities and help to create effective
counter strategies to gain competitive advantage. It strengthens R&D
pipelines by identifying new targets and MOAs to produce first-in-class and
best-in-class products.
The report is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put
together by Global Markets Direct’s team. Drug profiles/records featured in
the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set
of information

4. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Scope:
• The report reviews key players involved in the therapeutics
development for Hyperuricemia and enlists all their major and
minor projects
• The report summarizes all the dormant and discontinued pipeline
projects
• A review of the Hyperuricemia products under development by
companies and universities/research institutes based on
information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
Hyperuricemia Pipeline Review and Drug
Analysis 2015

5. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Reasons to Buy:
• Develop strategic initiatives by understanding the focus areas of
leading companies
• Identify and understand important and diverse types of
therapeutics under development for Hyperuricemia
• Plan mergers and acquisitions effectively by identifying key
players of the most promising pipeline
• Devise corrective measures for pipeline projects by
understanding Hyperuricemia pipeline depth and focus of
Indication therapeutics
Hyperuricemia Pipeline Review and Drug
Analysis 2015

6. For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441
RnRMarkertResearch
RnRMarketResearch.com, an online repository of market research reports, offers in-depth
analysis of over 5000 market segments. RnR Market Research library has syndicated reports by
leading market research publishers across the globe.
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Hyperuricemia Pipeline Review and Drug
Analysis 2015